BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 37720552)

  • 21. Molecular mechanisms of phase separation and amyloidosis of ALS/FTD-linked FUS and TDP-43.
    Song J
    Aging Dis; 2023 Nov; ():. PubMed ID: 38029395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.
    Montalbano M; McAllen S; Cascio FL; Sengupta U; Garcia S; Bhatt N; Ellsworth A; Heidelman EA; Johnson OD; Doskocil S; Kayed R
    Neurobiol Dis; 2020 Dec; 146():105130. PubMed ID: 33065281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific RNA interactions promote TDP-43 multivalent phase separation and maintain liquid properties.
    Grese ZR; Bastos AC; Mamede LD; French RL; Miller TM; Ayala YM
    EMBO Rep; 2021 Dec; 22(12):e53632. PubMed ID: 34787357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pathophysiology of neurodegenerative disease: Disturbing the balance between phase separation and irreversible aggregation.
    Webber CJ; Lei SE; Wolozin B
    Prog Mol Biol Transl Sci; 2020; 174():187-223. PubMed ID: 32828466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Emerging Role for Post-translational Modifications in Regulating RNP Condensates in the Germ Line.
    Schisa JA; Elaswad MT
    Front Mol Biosci; 2021; 8():658020. PubMed ID: 33898525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FUS-ALS mutants alter FMRP phase separation equilibrium and impair protein translation.
    Birsa N; Ule AM; Garone MG; Tsang B; Mattedi F; Chong PA; Humphrey J; Jarvis S; Pisiren M; Wilkins OG; Nosella ML; Devoy A; Bodo C; de la Fuente RF; Fisher EMC; Rosa A; Viero G; Forman-Kay JD; Schiavo G; Fratta P
    Sci Adv; 2021 Jul; 7(30):. PubMed ID: 34290090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. More than a bystander: RNAs specify multifaceted behaviors of liquid-liquid phase-separated biomolecular condensates.
    Zheng H; Zhang H
    Bioessays; 2024 Mar; 46(3):e2300203. PubMed ID: 38175843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synaptic Paths to Neurodegeneration: The Emerging Role of TDP-43 and FUS in Synaptic Functions.
    Ling SC
    Neural Plast; 2018; 2018():8413496. PubMed ID: 29755516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase separation of RNA-binding proteins in physiology and disease: An introduction to the JBC Reviews thematic series.
    Shorter J
    J Biol Chem; 2019 May; 294(18):7113-7114. PubMed ID: 30948513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation.
    French RL; Grese ZR; Aligireddy H; Dhavale DD; Reeb AN; Kedia N; Kotzbauer PT; Bieschke J; Ayala YM
    J Biol Chem; 2019 Apr; 294(17):6696-6709. PubMed ID: 30824544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear-Import Receptors Counter Deleterious Phase Transitions in Neurodegenerative Disease.
    Odeh HM; Fare CM; Shorter J
    J Mol Biol; 2022 Jan; 434(1):167220. PubMed ID: 34464655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function.
    Murakami T; Qamar S; Lin JQ; Schierle GS; Rees E; Miyashita A; Costa AR; Dodd RB; Chan FT; Michel CH; Kronenberg-Versteeg D; Li Y; Yang SP; Wakutani Y; Meadows W; Ferry RR; Dong L; Tartaglia GG; Favrin G; Lin WL; Dickson DW; Zhen M; Ron D; Schmitt-Ulms G; Fraser PE; Shneider NA; Holt C; Vendruscolo M; Kaminski CF; St George-Hyslop P
    Neuron; 2015 Nov; 88(4):678-90. PubMed ID: 26526393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liquid-Liquid Phase Separation of TDP-43 and FUS in Physiology and Pathology of Neurodegenerative Diseases.
    Carey JL; Guo L
    Front Mol Biosci; 2022; 9():826719. PubMed ID: 35187086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ALS and FTD: Where RNA metabolism meets protein quality control.
    Mandrioli J; Mediani L; Alberti S; Carra S
    Semin Cell Dev Biol; 2020 Mar; 99():183-192. PubMed ID: 31254610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA-binding proteins with prion-like domains in health and disease.
    Harrison AF; Shorter J
    Biochem J; 2017 Apr; 474(8):1417-1438. PubMed ID: 28389532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of PML nuclear bodies in familial amyotrophic lateral sclerosis-frontotemporal dementia.
    Antoniani F; Cimino M; Mediani L; Vinet J; Verde EM; Secco V; Yamoah A; Tripathi P; Aronica E; Cicardi ME; Trotti D; Sterneckert J; Goswami A; Carra S
    Cell Death Discov; 2023 Jul; 9(1):248. PubMed ID: 37454169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations.
    Daigle JG; Lanson NA; Smith RB; Casci I; Maltare A; Monaghan J; Nichols CD; Kryndushkin D; Shewmaker F; Pandey UB
    Hum Mol Genet; 2013 Mar; 22(6):1193-205. PubMed ID: 23257289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytoplasmic functions of TDP-43 and FUS and their role in ALS.
    Birsa N; Bentham MP; Fratta P
    Semin Cell Dev Biol; 2020 Mar; 99():193-201. PubMed ID: 31132467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining RNA oligonucleotides that reverse deleterious phase transitions of RNA-binding proteins with prion-like domains.
    Guo L; Mann JR; Mauna JC; Copley KE; Wang H; Rubien JD; Odeh HM; Lin J; Lee BL; Ganser L; Robinson E; Kim KM; Murthy AC; Paul T; Portz B; Gleixner AM; Diaz Z; Carey JL; Smirnov A; Padilla G; Lavorando E; Espy C; Shang Y; Huang EJ; Chesi A; Fawzi NL; Myong S; Donnelly CJ; Shorter J
    bioRxiv; 2023 Sep; ():. PubMed ID: 37732211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TDP-43 Oligomerization and Phase Separation Properties Are Necessary for Autoregulation.
    Koehler LC; Grese ZR; Bastos ACS; Mamede LD; Heyduk T; Ayala YM
    Front Neurosci; 2022; 16():818655. PubMed ID: 35495061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.